Effect of vitamin D3 supplementation on blood pressure in adults: An updated meta-analysis

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 26, Issue 8, 2016, Pages 663-673

  Golzarand, M ^a   Shab Bidar, S ^a   Koochakpoor, G ^b   Speakman J, R ^c,d   Djafarian, K ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

Author keywords

Blood pressure; Cholecalciferol; Hypertension; Meta analysis; Vitamin D3 supplementation

Indexed keywords

CALCIUM; COLECALCIFEROL;

ADULT; ARTICLE; BLOOD PRESSURE; DATA EXTRACTION; HUMAN; HYPERTENSION; META ANALYSIS; MINERAL SUPPLEMENTATION; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; BLOOD; DIETARY SUPPLEMENT; DOSE RESPONSE; DRUG EFFECTS; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

BLOOD PRESSURE; CALCIUM; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

EID: 84973526748     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2016.04.011     Document Type: Article

References (78)

1. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P.K., He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365(9455):217-223.
2. Gu Q. Hypertension among adults in the United States 2011-2012, National Health and Nutrition Examination Survey.
3. Hutton B., Tetzlaff J., Yazdi F., Thielman J., Kanji S., Fergusson D., et al. Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analyses. Syst Rev 2013, 2:44.
4. Lackland D.T. Hypertension: joint national committee on detection, evaluation, and treatment of high blood pressure guidelines. Curr Opin Neurol 2013, 26(1):8-12.
5. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009, 338. b1665.
6. Hirani V., Cumming R.G., Le Couteur D.G., Naganathan V., Blyth F., Handelsman D.J., et al. Low levels of 25-hydroxy vitamin d and active 1,25-dihydroxyvitamin d independently associated with type 2 diabetes mellitus in older Australian men: the concord health and ageing in men project. J Am Geriatr Soc 2014, 62(9):1741-1747.
7. Damasiewicz M.J., Magliano D.J., Daly R.M., Gagnon C., Lu Z.X., Ebeling P.R., et al. 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol 2012, 13:55.
8. Lee J.H., O'Keefe J.H., Bell D., Hensrud D.D., Holick M.F. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?. J Am Coll Cardiol 2008, 52(24):1949-1956.
9. Jorde R., Figenschau Y., Emaus N., Hutchinson M., Grimnes G. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010, 55(3):792-798.
10. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the third National Health and Nutrition Examination Survey. Arch Intern Med 2007, 167(11):1159-1165.
11. Forman J.P., Curhan G.C., Taylor E.N. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008, 52(5):828-832.
12. Scragg R., Sowers M., Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the third National Health and Nutrition Examination Survey. Am J Hypertens 2007, 20(7):713-719.
13. Kunutsor S.K., Apekey T.A., Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol 2013, 28(3):205-221.
14. Chen W.R., Liu Z.Y., Shi Y., Yin da W., Wang H., Sha Y., et al. Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: a randomized placebo-controlled trial. Atherosclerosis 2014, 235(1):102-109.
15. Maki K.C., Rubin M.R., Wong L.G., McManus J.F., Jensen C.D., Lawless A. Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int J Food Sci Nutr 2011, 62(04):318-327.
16. Wu S.H., Ho S.C., Zhong L. Effects of vitamin D supplementation on blood pressure. South Med J 2010, 103(8):729-737.
17. Moher D., Liberati A., Tetzlaff J., Altman D.G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6(7):e1000097.
18. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17(1):1-12.
19. Shab-Bidar S., Bours S., Geusens P.P., Kessels A.G., van den Bergh J.P. Serum 25(OH)D response to vitamin D3 supplementation: a meta-regression analysis. Nutrition 2014, 30(9):975-985.
20. Shab-Bidar S., Bours S.P., Geusens P.P., van der Velde R.Y., Janssen M.J., van den Bergh J.P. Suboptimal effect of different vitamin D3 supplementations and doses adapted to baseline serum 25(OH)D on achieved 25(OH)D levels in patients with a recent fracture: a prospective observational study. Eur J Endocrinol 2013, 169(5):597-604.
21. Bischoff-Ferrari H.A., Dawson-Hughes B., Stocklin E., Sidelnikov E., Willett W.C., Edel J.O., et al. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure, and markers of innate immunity. J Bone Min Res 2012, 27(1):160-169.
22. Kunutsor S.K., Burgess S., Munroe P.B., Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon?. Eur J Epidemiol 2014, 29(1):1-14.
23. Morton S.C., Adams J.L., Suttorp M.J., Shekelle P.G. Meta-regression approaches: what, why, when, and how? 2004, Rockville MD.
24. Chai W., Cooney R.V., Franke A.A., Bostick R.M. Effects of calcium and vitamin D supplementation on blood pressure and serum lipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 2013, 23(9):564-570.
25. Forman J.P., Scott J.B., Ng K., Drake B.F., Suarez E., Hayden D.L., et al. Effect of vitamin d supplementation on blood pressure in blacks. Hypertension 2013, 61(4):779-785.
26. Gepner A.D., Ramamurthy R., Krueger D.C., Korcarz C.E., Binkley N., Stein J.H. A prospective randomized controlled trial of the effects of Vitamin D supplementation on cardiovascular disease risk. PLoS One 2012, 7(5).
27. Jorde R., Sneve M., Torjesen P., Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year: original article. J Intern Med 2010, 267(5):462-472.
28. Larsen T., Mose F.H., Bech J.N., Hansen A.B., Pedersen E.B. Effect of cholecalciferol supplementation during winter months in patients with hypertension: a randomized, placebo-controlled trial. Am J Hypertens 2012, 25(11):1215-1222.
29. Longenecker C.T., Hileman C.O., Carman T.L., Ross A.C., Seydafkan S., Brown T.T., et al. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir Ther 2012, 17(4):613.
30. Muldowney S., Lucey A.J., Hill T.R., Seamans K.M., Taylor N., Wallace J.M.W., et al. Incremental cholecalciferol supplementation up to 15 μg/d throughout winter at 51-55° N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. J Nutr 2012, 142(8):1519-1525.
31. Nagpal J., Pande J.N., Bhartia A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009, 26(1):19-27.
32. Nasri H., Behradmanesh S., Ahmadi A., Rafieian-Kopaei M. Impact of oral vitamin D (cholecalciferol) replacement therapy on blood pressure in type 2 diabetes patients; a randomized, double-blind, placebo controlled clinical trial. J Nephropathol 2014, 3(1):29-33.
33. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86(4):1633-1637.
34. Raja-Khan N., Shah J., Stetter C.M., Lott M.E., Kunselman A.R., Dodson W.C., et al. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Fertil Steril 2014, 101(6):1740-1746.
35. Salehpour A., Shidfar F., Hosseinpanah F., Vafa M., Razaghi M., Hoshiarrad A., et al. Vitamin D3 and the risk of CVD in overweight and obese women: a randomised controlled trial. Br J Nutr 2012, 108(10):1866-1873.
36. Schleithoff S.S., Zittermann A., Tenderich G., Berthold H.K., Stehle P., Koerfer R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006, 83(4):754-759.
37. Scragg R., Slow S., Stewart A.W., Jennings L.C., Chambers S.T., Priest P.C., et al. Long-term high-dose Vitamin D3 supplementation and blood pressure in healthy adults: a randomized controlled trial. Hypertension 2014, 64(4):725-730.
38. Sollid S.T., Hutchinson M.Y., Fuskevag O.M., Figenschau Y., Joakimsen R.M., Schirmer H., et al. No effect of high-dose vitamin D supplementation on glycemic status or cardiovascular risk factors in subjects with prediabetes. Diabetes Care 2014, 37(8):2123-2131.
39. Stricker H., Tosi Bianda F., Guidicelli-Nicolosi S., Limoni C., Colucci G. Effect of a single, oral, high-dose vitamin D supplementation on endothelial function in patients with peripheral arterial disease: a randomised controlled pilot study. Eur J Vasc Endovasc Surg 2012, 44(3):307-312.
40. Witham M.D., Dove F.J., Dryburgh M., Sugden J.A., Morris A.D., Struthers A.D. The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53(10):2112-2119.
41. Witham M.D., Dove F.J., Khan F., Lang C.C., Belch J.J.F., Struthers A.D. Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction - a randomised controlled trial. Int J Cardiol 2013, 167(3):745-749.
42. Witham M.D., Price R.J.G., Struthers A.D., Donnan P.T., Messow C.-M., Ford I., et al. Cholecalciferol treatment to reduce blood pressure in older patients with isolated systolic hypertension: the VitDISH randomized controlled trial. JAMA Intern Med 2013, 173(18):1672-1679.
43. Wood A.D., Secombes K.R., Thies F., Aucott L., Black A.J., Mavroeidi A., et al. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012, 97(10):3557-3568.
44. Yiu Y.-F., Yiu K.-H., Siu C.-W., Chan Y.-H., Li S.-W., Wong L.-Y., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227(1):140-146.
45. Zittermann A., Frisch S., Berthold H.K., Götting C., Kuhn J., Kleesiek K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89(5):1321-1327.
46. Pilz S., Gaksch M., Kienreich K., Grubler M., Verheyen N., Fahrleitner-Pammer A., et al. Effects of Vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial. Hypertension 2015, 65(6):1195-1201.
47. Tabesh M., Azadbakht L., Faghihimani E., Esmaillzadeh A. Effects of calcium plus vitamin D supplementation on anthropometric measurements and blood pressure in vitamin D insufficient people with type 2 diabetes: a randomized controlled clinical trial. J Am Coll Nutr 2015, 34(4):281-289.
48. Witham M.D., Dove F.J., Khan F., Lang C.C., Belch J.J., Struthers A.D. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction-a randomised controlled trial. Int J Cardiol 2013, 167(3):745-749.
49. Mozaffari-Khosravi H., Loloei S., Mirjalili M.R., Barzegar K. The effect of vitamin D supplementation on blood pressure in patients with elevated blood pressure and vitamin D deficiency: a randomized, double-blind, placebo-controlled trial. Blood Press Monit 2015, 20(2):83-91.
50. Sadiya A., Ahmed S.M., Carlsson M., Tesfa Y., George M., Ali S.H., et al. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial. Eur J Clin Nutr 2014.
51. Moghassemi S., Marjani A. The effect of short-term vitamin D supplementation on lipid profile and blood pressure in post-menopausal women: a randomized controlled trial. Iran J Nurs Midwifery Res 2014, 19(5):517-521.
52. Witham M.D., Adams F., Kabir G., Kennedy G., Belch J.J., Khan F. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK-a randomised controlled trial. Atherosclerosis 2013, 230(2):293-299.
53. Witham M.D., Nadir M.A., Struthers A.D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens 2009, 27(10):1948-1954.
54. Beveridge L.A., Struthers A.D., Khan F., Jorde R., Scragg R., Macdonald H.M., et al. Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data. JAMA Intern Med 2015, 175(5):745-754.
55. Carrara D., Bernini M., Bacca A., Rugani I., Duranti E., Virdis A., et al. Cholecalciferol administration blunts the systemic renin-angiotensin system in essential hypertensives with hypovitaminosis D. J Renin Angiotensin Aldosterone Syst 2014, 15(1):82-87.
56. Zittermann A., Koerfer R. Vitamin D in the prevention and treatment of coronary heart disease. Curr Opin Clin Nutr Metabolic Care 2008, 11(6):752-757.
57. Hamdan S., Roussel L., Gleyses X., Chevallereau G., Schott A.M., Beauchet O., et al. Detection of hypovitaminosis D in older adults: a classification tree analysis. J Am Geriatr Soc 2014, 62(6):1193-1195.
58. Thomas M.K., Lloyd-Jones D.M., Thadhani R.I., Shaw A.C., Deraska D.J., Kitch B.T., et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998, 338(12):777-783.
59. Gallagher J.C., Yalamanchili V., Smith L.M. The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women. J Steroid Biochem Mol Biol 2013, 136:195-200.
60. Bolland M.J., Barber P.A., Doughty R.N., Mason B., Horne A., Ames R., et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008, 336(7638):262-266.
61. Xiao Q., Murphy R.A., Houston D.K., Harris T.B., Chow W.H., Park Y. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 2013, 173(8):639-646.
62. Bolland M.J., Grey A., Avenell A., Gamble G.D., Reid I.R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 2011, 342. d2040.
63. Barry E.L., Mott L.A., Melamed M.L., Rees J.R., Ivanova A., Sandler R.S., et al. Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One 2014, 9(10):e108094.
64. Bolland M.J., Avenell A., Baron J.A., Grey A., MacLennan G.S., Gamble G.D., et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010, 341. c3691.
65. Bostick R.M., Fosdick L., Grandits G.A., Grambsch P., Gross M., Louis T.A. Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial. Arch Fam Med 2000, 9(1):31-38. discussion 39.
66. Dickinson H.O., Nicolson D.J., Cook J.V., Campbell F., Beyer F.R., Ford G.A., et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006, (2). CD004639.
67. Margolis K.L., Ray R.M., Van Horn L., Manson J.E., Allison M.A., Black H.R., et al. Effect of calcium and vitamin D supplementation on blood pressure: the women's health initiative randomized trial. Hypertension 2008, 52(5):847-855.
68. Reid I.R., Ames R., Mason B., Bolland M.J., Bacon C.J., Reid H.E., et al. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr 2010, 91(1):131-139.
69. van Mierlo L.A., Arends L.R., Streppel M.T., Zeegers M.P., Kok F.J., Grobbee D.E., et al. Blood pressure response to calcium supplementation: a meta-analysis of randomized controlled trials. J Hum Hypertens 2006, 20(8):571-580.
70. Lee S.W., Kim M., Kim H., Han S.S., Lee H., Lee J.P., et al. Obesity modifies the association between serum 25-hydroxyvitamin D and insulin resistance in Korean general population without increased fasting glucose levels. Tohoku J Exp Med 2014, 234(2):89-97.
71. Pourshahidi L.K. Vitamin D and obesity: current perspectives and future directions. Proc Nutr Soc 2014, 1-10.
72. Dhaliwal R., Mikhail M., Feuerman M., Aloia J.F. The vitamin D dose response in obesity. Endocr Pract 2014, 1-25.
73. Pittas A.G., Chung M., Trikalinos T., Mitri J., Brendel M., Patel K., et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152(5):307-314.
74. Thierry-Palmer M., Cephas S., Sayavongsa P., Doherty A., Arnaud S.B. Dahl salt-sensitive rats develop hypovitaminosis D and hyperparathyroidism when fed a standard diet. Bone 2005, 36(4):645-653.
75. Thierry-Palmer M., Doherty A., Bayorh M.A., Griffin K. Dahl salt-sensitive rats excrete 25-hydroxyvitamin D into urine. J Nutr 2003, 133(1):187-190.
76. Thierry-Palmer M., Cephas S., Muttardy F.F., Al-Mahmoud A. High dietary cholecalciferol increases plasma 25-hydroxycholecalciferol concentration, but does not attenuate the hypertension of Dahl salt-sensitive rats fed a high salt diet. J Steroid Biochem Mol Biol 2008, 111(1-2):7-12.
77. Simmonds M. Quantifying the risk of error when interpreting funnel plots. Syst Rev 2015, 4:24.
78. Anzures-Cabrera J., Higgins J.P. Graphical displays for meta-analysis: an overview with suggestions for practice. Res Synth Methods 2010, 1(1):66-80.